Olanzapine Injection, Powder, For Solution
Product Images NDC 0781-9105

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 0781-9105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Olanzapine 01)

Chemical structure diagram of Olanzapine, illustrating its molecular framework with labeled nitrogen, sulfur, and carbon atoms consistent with the active ingredient identified as Olanzapine.*

FDA Label Image

Vial Label (Olanzapine 02)

Label for Olanzapine for Injection 10 mg/vial, powder for solution, intramuscular use only. The sterile single-use vial is labeled with NDC 0781-9105-72, manufactured by Gland Pharma Limited for Sandoz Inc. The label includes usage instructions, manufacturing details, and a barcode. Marked for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.